Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Plantago (Psyllium) and Colitis: Evidence Overview

Plantago, specifically Plantago ovata seed husk (psyllium), is used as a dietary fiber supplement and has been researched for its effects in managing colitis, particularly ulcerative colitis. Several clinical studies have investigated psyllium's role in maintaining remission in ulcerative colitis patients. A notable randomized controlled trial published in The Lancet (1999) found that psyllium was as effective as mesalamine, a standard anti-inflammatory drug, in maintaining remission over a 12-month period. Other studies have shown that supplementation with psyllium can improve stool consistency and bowel regularity, which may be beneficial for individuals with colitis experiencing diarrhea or irregularity.

The proposed mechanisms include psyllium's ability to form a gel-like substance that modulates water content in the colon, supports beneficial gut microbiota, and may have mild anti-inflammatory effects. However, while the data is promising, the overall body of evidence is limited by small sample sizes and variability in study quality. Most positive findings relate to maintenance of remission rather than treatment of acute flares. Authoritative guidelines, such as those from the American College of Gastroenterology, do not yet recommend Plantago as a primary treatment but acknowledge its potential as an adjunct for some patients.

In summary, there is moderate scientific support for Plantago's use in maintaining remission in ulcerative colitis, but it is not a replacement for conventional therapy. More large-scale, high-quality trials are needed to clarify its role in colitis management.

More about Plantago
More about Colitis

Other ingredients used for Colitis

Other health conditions supported by Plantago

Products containing Plantago